Healthcare News
 Updated 3 times daily.
 Select a news topic:
Appetite Hormones May Predict Weight Regain After Dieting Thu, 09 Sep 2010
Many people have experienced the frustration that comes with regaining weight that was lost from dieting. According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), the levels of appetite hormones in the body prior to dieting may serve as a predictor of weight regain after dieting...
Study Of Health Effects Of Botanical Estrogens Thu, 09 Sep 2010
An ongoing research initiative into the health effects of botanical estrogens will get an $8 million boost from the National Institutes of Health. The Botanical Research Center, based at the University of Illinois, will draw on the expertise of a multidisciplinary team of researchers to address the many unknowns associated with use of botanical estrogens...
Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia Thu, 09 Sep 2010
Enobia Pharma provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages...
Weight Loss Raises Industrial Pollutant Levels In Blood Wed, 08 Sep 2010
People with long-term weight loss have higher levels of persistent organic pollutants in their blood, which are known to increase the risk of developing rheumatoid arthritis, high blood pressure (hypertension) and diabetes, according to an article published today in the International Journal of Obesity...
Johns Hopkins Researchers Unravel Clues To Infertility Among Obese Women Wed, 08 Sep 2010
Obese women have a well-known risk for infertility, but a new Johns Hopkins Children's Center study has unraveled what investigators there believe is the mechanism that accounts for the risk. The research, conducted in mice and published online on Sept...
The Benefits Of Hormone Replacement Therapy Overstated And Harms Downplayed By Ghostwritten Articles Wed, 08 Sep 2010
The first academic analysis of the 1500 documents unsealed in recent litigation against the pharmaceutical giant Wyeth (now part of Pfizer) reveals unprecedented insights into how pharmaceutical companies use ghostwriters to insert marketing messages into articles published in medical journals. Dr...
Experts Recommend Universal Screening Of Newborns For Congenital Adrenal Hyperplasia Wed, 08 Sep 2010
The Endocrine Society released a new clinical practice guideline on the diagnosis and treatment of congenital adrenal hyperplasia (CAH). The guideline features a series of evidence-based clinical recommendations developed by an expert task force...
Universal Screening Of Newborns For Congenital Adrenal Hyperplasia Recommended Tue, 07 Sep 2010
Today, The Endocrine Society released a new clinical practice guideline on the diagnosis and treatment of congenital adrenal hyperplasia (CAH). The guideline features a series of evidence-based clinical recommendations developed by an expert task force...
Stress Resilience Returns With Feeling For Rhythm Tue, 07 Sep 2010
If your body releases cortisol with fixed regularity then you can cope with stress better, says NWO-funded researcher Angela Sarabdjitsingh. She investigated the rhythm of corticosterone production in rats. This rat hormone is comparable to the human stress hormone cortisol. Rats deal considerably less well with stress if the pattern of corticosterone release changes...
Paris Will Host The 14th International Thyroid Congress From September 11th To 16th, 2010 Mon, 06 Sep 2010
Held every five year, the International Thyroid Congress is a key worldwide event for healthcare professionals around the world. Over 2,500 people are expected: endocrinologists, nuclear medicine physicians, oncologists, ENT specialists, surgeons, researchers, GPs, caregivers, biologists, etc...
Position Statements About The Post-Reproductive Health Of Women Published By EMAS Sat, 04 Sep 2010
Elsevier has announced the publication of four important position statements from the European Menopause and Andropause Society (EMAS) in the journal Maturitas on common management problems in the post-reproductive health of women. The statements cover the management of the menopause in the context of obesity, epilepsy, endometriosis and premature ovarian failure...
Cortisol Levels In Hair Linked To Heart Attack Risk Sat, 04 Sep 2010
Cortisol levels in hair may be the first biomarker to measure chronic (long-term) stress, which is linked to a higher risk of having a heart attack (acute myocardial infarction), according to a new study published in the medical journal Stress...
European Menopause And Andropause Society Publishes Four Position Statements About The Post-reproductive Health Of Women Fri, 03 Sep 2010
Elsevier announced the publication of four important position statements from the European Menopause and Andropause Society (EMAS) in the journal Maturitas on common management problems in the post-reproductive health of women. The statements cover the management of the menopause in the context of obesity, epilepsy, endometriosis and premature ovarian failure...
New Evidence That Fat Cells Are Not Just Dormant Storage Depots For Calories Thu, 02 Sep 2010
Scientists are reporting new evidence that the fat tissue in those spare tires and lower belly pooches - far from being a dormant storage depot for surplus calories - is an active organ that sends chemical signals to other parts of the body, perhaps increasing the risk of heart attacks, cancer, and other diseases...
Why Females Fare Better Than Males After Traumatic Injury Thu, 02 Sep 2010
A study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estrogen). In the study, the Estradiol prevented vascular permeability following hemorrhagic shock...
Bone Hormone Levels Linked To Risk Of Death For Patients With Heart Failure Wed, 01 Sep 2010
Patients suffering with heart failure are more likely to die if they have high levels of a bone hormone called osteoprotegerin (OPG). That is the finding of a research team from the Akershus University Hospital and the University of Oslo in Norway, in collaboration with colleagues in Italy and Denmark...
BPA And Testosterone Levels: First Evidence For Small Changes In Men Thu, 26 Aug 2010
An international group of researchers led by the Peninsula Medical School and the University of Exeter have for the first time identified changes in sex hormones associated with BPA exposure in men, in a large population study. The study results are published in the latest issue of Environmental Health Perspectives...
Insulin Resistance, Type 2 Diabetes Linked To Plaques Associated With Alzheimer's Disease Thu, 26 Aug 2010
People with insulin resistance and type 2 diabetes appear to be at an increased risk of developing plaques in the brain that are associated with Alzheimer's disease, according to new research published in the August 25, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology...
Premenstrual Syndrome (PMS) Symptoms Worse If Woman Feels Stressed Early In Menstrual Cycle Wed, 25 Aug 2010
Women who feel stressed early on during their menstrual cycle are more likely to have more severe symptoms during and before menstruation, says a report conducted by researchers at the NIH (National Institutes of Health, USA) and other centers...
Researchers Develop New Laboratory Cell Lines To Study Treatment For Anaplastic Thyroid Cancer Wed, 25 Aug 2010
To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world...
PROLOR Biotech Receives FDA Clearance For A Phase II Trial Of Its Long-Acting Human Growth Hormone In The U.S. Wed, 25 Aug 2010
PROLOR Biotech, Inc. (NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP...
Two-Year Data From Phase 2 Trial Of Genzyme's Eliglustat Tartrate For Gaucher Disease To Be Published In The Journal Blood Tue, 24 Aug 2010
Genzyme Corporation (NASDAQ: GENZ) announced that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers...
Bonding By Oxytocin In The Transition To Fatherhood Mon, 23 Aug 2010
The hormone oxytocin has come under intensive study in light of emerging evidence that its release contributes to the social bonding that occurs between lovers, friends, and colleagues. Oxytocin also plays an important role in birth and maternal behavior, but until now, research had never addressed the involvement of oxytocin in the transition to fatherhood...
Male Menopause Affects More Than Five Million Men Sat, 21 Aug 2010
While most frequently associated with women's health, age-related hormone changes, often dubbed menopause, can occur in men as well, causing symptoms of fatigue, mood swings, decreased desire for sex, hair loss, lack of concentration and weight gain. Experts estimate that more than 5 million men are affected, yet worry the number may be considerably higher since symptoms are frequently ignored...
Repros Requests Type B Meeting With FDA To Discuss Phase III Protocols For Androxal(R) Fri, 20 Aug 2010
Repros Therapeutics Inc. (NasdaqCM:RPRX) announced that the Company has requested a Type B Meeting in order to review the Company's Phase III protocols for Androxal® in the treatment of secondary hypogonadism. Androxal is an oral drug that normalizes both testosterone and sperm levels. Larry I...
Copyright © 1998-2006 Silver Oak Search Consultants, Inc. All Rights Reserved.